[Primary antiphospholipid syndrome in combination with heterozygous mutation in prothrombin (G20210A) gene: a case

Klinicheskaia Meditsina
|December 11, 2002
PubMed

A 47-year-old man had residual effects of acute disorders of cerebral circulation in the territory of the median cerebral artery. Computer tomography confirmed the presence of the postischemic focus in the area of the head of the caudate nucleus. Also, thrombosis of small branches of the coronary arteries with development of postinfarction cardiosclerosis and arrhythmia, thrombosis of deep veins in the left leg gave grounds for verification of primary antiphospholipid syndrome (PAS). The diagnosis was serologically confirmed by the presence of anticardiolipin antibodies and the presence of lupus anticoagulant. A genetic examination detected heterozygous mutation G20210A in prothrombin gene but failed to identify G1691A (Leiden) mutation in gene of factor V and C677T in gene 5,10-methylentetrahydrofolatreductase. A family history was collected. Thrombotic complications were found in grandmother and aunt (by mother), in sister and brother. The latter had also a heterozygous mutation of prothrombin gene. Genetic mutations in PAS patients are an additional risk factor of recurrent thrombosis.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...